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Systematic reviewAim: To identify known risk factors for mortality for adult patients, discharged from hospital with diabetes.
Method: The systematic review was based on the PRISMA protocol. Studies were identified through EMBASE &
MEDLINE databases. The inclusion criteria were papers that were published over the last 6 years, in English lan-
guage, and focused on risk factors of mortality in adult patients with diabetes, after they were discharged from
hospitals. Thiswas followed by data extraction “with quality assessment and semi-quantitative synthesis accord-
ing to PRISMA guidelines”.
Results: There were 35 studies identified, considering risk factors relating to mortality for patients, discharged
from hospital with diabetes. These studies are distributed internationally. 48 distinct statistically significant
risk factors for mortality can be identified. Risk factors can be grouped into the following categories; demo-
graphic, socioeconomic, lifestyle, patient medical, inpatient stay, medication related, laboratory results, and
gylcaemic status. These risk factors can be further divided into risk factors identified in generalized populations
of patients with diabetes, compared to specific sub-populations of people with diabetes.
Conclusion: A relatively small number of studies have considered risk factors relating to mortality for patients,
discharged from hospital with a diagnosis of diabetes. Mortality is an important outcome, when considering dis-
charge from hospital with diabetes. However, there has only been limited consideration within the research
literature.
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Patients with diabetes are known to be at an increased risk of com-
plications and mortality during their inpatient stay.1,2 Significant re-
search and resource has been invested into understanding how to
reduce this burden of inpatient mortality for patients with diabetes.3,4
There has been much less focus on the risk of mortality, following dis-
charge from hospital with diabetes. Data available on post discharge
outcomes, in this patient population, is not abundant and is ambiguous.5
There is evidence of an increased risk of mortality for patients with dia-
betes; however, tools for predicting mortality in such patients are not
easily available.6 This study, therefore, aims to systematically identify
the known risk factors for mortality in patients with diabetes, after
they are discharged from hospitals.
This work builds on a previous published work, considering risk fac-
tors for readmission of patients discharged fromhospitalwith diabetes.7
Readmission is a commonly considered measure of care quality, when
patients are discharged from hospital, and, therefore, has been more
closely studied than mortality following hospital discharge, arguably
due to financial incentives and costs associated with readmission
rates.8 Both readmission and mortality are, however, important out-
comemeasures, when considering the discharge of patients with diabe-
tes and the subsequent development of risk prediction models. The
consideration of which patients are at a greatest risk of mortality, fol-
lowing discharge, will help allocated limited resources to supporting
this population.
The identification of risk factors, in this manner, has the potential to
support research that enables us to predict mortality in patients withRecords identified through 3 database 
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Full-text articles assessed for eligibility  
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Fig. 1. PRISMA flow diagra
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and understood, they can be identified in the patient's individual Elec-
tronic Health Record (EHR). Understanding risk factors, relevant to pa-
tients discharged from hospital with diabetes, is important to patients,
carers, healthcare practitioners and researchers. It supports the delivery
and development of individualised medicine, based on each patient's
underlying risks; supports our understanding of regional variations in
readmission risk; and, supports development of evidence based inter-
ventions, targeted at reducing readmission risks. Interestingly, the pau-
city of research in this area, for diabetes, is in direct contrast to other
medical conditions, such as heart failure.9
2. Methods
2.1. Search strategy
The systematic review was performed according to the PRISMA
protocol.10 The PRISMA flowchart is shown in Fig. 1.
2.2. Study selection
The literature searchwas conducted in theMEDLINE, EMBASE & En-
gineeringVillage databases. Search termsused to identify relevantmed-
ical literature were ((“diabetes” AND “discharge”)) AND (“mortality” or
“death” or “died”). Filters were applied to identify studies that were
published, in English language, over the last 6 years (March 2014 to Feb-
ruary 2020), to include themost recent clinical evidence available in this
area of research. Additionally, filters were applied to set participants'Records excluded (n = 2,679) 
Full-text articles excluded  
(n = 177) 
[Risk of other diseases / events with T2D = 
21 
Diabetes as a risk factor of other conditions 
= 47  
In-hospital mortality = 31 
Management of diabetes = 22 
Off topic = 56] 
Duplicates excluded  
(n = 545)  
Automatic = 420 and manual = 125] 
m of study selection.
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Table 1
*Comprising of: 10 retrospective cohort, 4 retrospective analysis, 2 retrospective case con-
trol, 1 retrospective observational 1 retrospective registry and 1 retrospective risk predic-
tion modeling.
Study design Number of papers Percentage of papers (%)
Retrospective study⁎ 19 54
Prospective study 10 29
Registry based 5 14
Post hoc analysis 1 3
Table 2
Distribution of study geographies.
Study location #
studies
Study
location
#
studies
Study location #
studies
United States 3 Canada 1 Spain 1
Australia 2 China 1 Middle East 1
Brazil 2 Croatia 1 Romania & Germany 1
Greece 2 Finland 1 USA & EU 1
Italy 2 Germany 1
Taiwan 2 Israel 1
United Kingdom 2 Latvia 1
3T. Mukherjee et al. / Journal of Diabetes and Its Complications xxx (xxxx) xxxage as 18 years and above, as this research looked at only adult patients.
Any study that focused on in-hospitalmortality or diabetes, as a risk fac-
tor for other clinical conditions, was excluded.2.3. Data extraction
Data was extracted to a pre-determined, data-extraction proforma.
Data was extracted based on the following variables; year of publica-
tion, type of study, location of research, sample size, sub population of
people with diabetes, statistically significant risk factors and statistical
tests for analysis. Additionally, risk factors not meeting significance
criteria, but had impact were also extracted. Data extraction was per-
formed independently by two authors, with any discrepancies resolved
by a third author.2.4. Quality assessment
All studies included in the review were assessed for study quality.
Data was extracted using Keshav's 5Cs (category, context, correctness,
contribution and clarity),11 alongside sample size, justification of their
participant selection and statistical tests applied. Papers were not ex-
cluded based on producing a negative outcome or being a low quality
study.2.5. Data synthesis
The diversity among the identified studies, in terms of their sample
sizes and patient population with various co-morbidities apart from di-
abetes, did not allow a meta-analysis to be conducted. Instead, both a
semi-quantitative and narrative summary of identified prognostic risk
factors were performed. Individual risk factors have then been grouped
under broader categories, as and when necessary.0
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3.1. Search results
3436 studieswere identified from the literature search, representing
2891 studies following removal of duplicates. Title and abstract based
screening resulted in 2679 articles being removed, which left 212 for
full text assessment. Full text evaluation resulted in 35 articles being
shortlisted for the review (Fig. 1).
3.2. Study characteristics
From the 35 articles identified, 29 were full text articles (83%) and 6
(17%) were only in abstract form, typically from conference presenta-
tions (Table 1).
The study designs noted within the review were:
The distribution of studies over time is described in Fig. 2:
(11%) studies were based on international datasets, 12studies (34%)
were conducted based on national data, 9studies (26%) used regional
data, 10 (29%) were single-centre studies. The distribution of study ge-
ographies is shown in Table 2:
3.3. Risk factor identification
The majority of studies analysed (24studies, 69%) identified one or
more statistically significant risk factors for mortality, following dis-
charge from hospital with a co-morbid diagnosis of diabetes. There
were 11 studies (31%),which identified no statistical significant risk fac-
tors. The distribution of risk factors is demonstrated in more detail in
Table 3.
The follow up period, during which mortality was looked for in the
studies, was highly variable. The most common follow up period was017 2018 2019 2020
ear 
r time 
over time.
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Table 3
Study characteristics.
Ref Year Data
collection
Sample
size
Sub-population Significant risk factors No. of
significant
risk factors
Follow
up
period
(years)
12 2017 Regional 22,473 Post Intensive Care Unit (ICU) Hospital, age, sex, ethnicity, APACHE score, co-morbidity 6 5.1
13 2016 National 1613 Post Myocardial Infarction (MI) Admission creatinine, employment, age, Haemoglobin (Hb), Left
Ventricular Systolic Dysfunction (LVSD), co-morbidity, activity, in
hospital revascularisation, BMI, insulin, fasting blood glucose, angina
frequency
12 5
14 2017 Regional 59,412 All diabetes Not specific 0 Until
death
15 2018 Single 312 Age over 60 Gait speed, calf circumference (BMI) 2 NA
16 2015 Single 4607 All diabetes Age, Gender, Cardiovascular diseases and infectious diseases
(co-morbidity)
4 337
days
17 2014 National 1082 Heart failure Age, co-morbidity, sodium (biochemistry), anaemia (haematology),
medication, BMI, NHYA (severity scoring)
7 1
18 2015 National 2904 Chronic Kidney Disease (CKD) and acute MI
admission
0 0 1
19 2015 National 4054 Admission for acute MI Statins prior to acute MI, number of medications 2 3
20 2018 Single 207 Diabetic Ketoacidosis
(DKA) diagnosed
Age, duration of diabetes, number of hospitalisations 3 5
21 2016 Single 409 Admitted with pneumonia Hospitalization for pneumonia (admission diagnosis)
Age, haemodialysis (procedure)
Charlson co-morbidity index (score)
renal insufficiency, pleural effusion, malnutrition (co-morbidity)
pH < 7.35 (biochemistry)
8 1
22 2017 Single 761 Admitted with poor glucose control Estimated Glomerular Filtration Rate (eGFR), Albuminuria
(biochemistry)
2 6.6
23 2016 International 5005 Patients admitted with acute
decompensated heart failure with diabetes
BMI (underweight, severely obese) 2 1
24 2018 Single 304 All diabetes 0 0 1
25 2019 Regional 104,525 Patients hospitalised and dispensed
prescription for insulin and/or OHA within 8
days of discharge. Age > 66 years
new insulin use (medication) 1 30 days
26 2018 Single 130 Type 2 Diabetes Mellitus (T2DM) 0 0 30 days
27 2017 Single 304 T2DM patients with first ever
noncardioemobolic acute ischemic stroke
Age, Stroke severity (NIHSS scale), clopidogrel compared to aspirin
(medication) co-morbidity
4 10
28 2016 National 386 DKA admitted to Intensive Treatment Unit
(ITU)
Age, APACHEII score, mechanical ventilation, number of organs
supported, DKA severity, creatinine, bilirubin, pCO2 (biochemistry),
lowest Glasgow Coma Score (GCS)
9 5
29 2016 Regional 214,991 All diabetes Age, sex, Charlson index 3 2
30 2018 National 17,186 Diabetes and heart failure 0 0 NA
31 2016 National 1743 Diabetes and Acute Coronary Syndrome
(ACS)
0 0 6
months
32 2019 National 843,978 All diabetes 0 0 6
months
33 2017 National 71,640 Diabetes and cancer 0 0 3
34 2017 Regional 28,353 All diabetes Median glucose during admission & glucose variability 2 6
35 2015 International 221 T2DM admitted with ACS 0 0 1
36 2014 International 1998 Patients hospitalised with worsening heart
failure and an ejection fraction below 40%
0 0 9.9
months
37 2017 Regional 218 Haematocrit, EF, ACEi. Red blood cell
distribution
0 0 1
38 2017 Single 202 All diabetes hba1c, insulin resistance 2 2.5
39 2020 International 974 ACS Fibrinolysis 1 1
40 2019 Single 306 All diabetes Sarcopenia 1 2
41 2019 Regional 10,542 All diabetes Heat wave intensity 1 NA
42 2019 National 13,113 Heart failure Diabetes and heart failure 1 1
43 2019 National 41,776 Heart failure 0 0 1
44 2019 Regional NA All diabetes Pharmacy follow up 1 90 days
45 2019 National 1221 Acute MI Insulin prescription at discharge 1 5
46 2019 Regional 100,000 T2DM over 40 years Lower limb amputation, sex 2 10
4 T. Mukherjee et al. / Journal of Diabetes and Its Complications xxx (xxxx) xxx12 months in 8 studies (23%). The shortest follow up period was 1
month and the longest follow up period was 10 years.
The extracted studies varied according to whether they considered
risk in all patients with diabetes (6 studies, 17%) or a specific sub popu-
lation. Those sub populations were defined either by the type of diabe-
tes, or the characteristics relevant to the inpatient stay, and are
demonstrated in more detail in Table 3.
In total, there were 48 distinct risk factors identified. These can be
grouped into risk factor categories, alongside grouping according to
whether they were identified for all patients with diabetes. The resultsPlease cite this article as: T.Mukherjee, T. Robbins, S.N. LimChoi Keung, et a
discharged from hospital with..., Journal of Diabetes and Its Complicationsof this grouping is shown in Table 4, which represents a complete list
of all statistically significant risk factors identified within the published
research literature, alongside the number (and references) of studies,
which identified these risk factors as significant.
3.4. Study quality
The sample size of extracted studies varied between 130participants
and 843,978 participants. Themean average number of participants per
study was 44,484, with a median of 1743 participants.l., A systematic review considering risk factors formortality of patients
, https://doi.org/10.1016/j.jdiacomp.2020.107705
Table 4
Risk factors.
Risk factors for specific diabetes
subpopulations
Risk factors in general diabetes
populations
Risk factor Number of studies
&
Ref
Risk Factor No.&
Ref
Demographic
Age 712,13,17,20,21,24,27,28 Age 216,29
Gender 112,46 Gender 216,29
Race 112
Socioeconomic status
Employment status 113
Lifestyle
Leisure time activity 113
External factors
Weather conditions 141
Patient medical factors
Co-morbidity 612,13,17,25,27,42 Co-morbidity 216,29,40
Malnutrition 121
Duration of diabetes 120
Severity score 412,17,27,28
DKA Severity 147
Body mass index 313,17,23
Gait speed 115
Calf circumference 115
Angina frequency 113
Inpatient stay factors
Procedure 213,21,46
Admission diagnosis 121
Length of stay 124
Glasgow coma score
(GCS)
128
Mechanical ventilation 128
Number of organs
supported
128
No. of hospitalisations 120
Which hospital admitted
to
112
Medication related
Beta blocker 117 Pharmacy follow up 144
ACEi/ARB blocker 117
Statins prior to AMI 119
No. of medications at
discharge
119
Insulin use 125,45
Clopidogrel 127
Laboratory results
Admission creatinine 213,28 Hba1c 138
Fasting glucose 113
Sodium level 117
pH below 7.35 121
eGFR 122
Albuminura 122
Bilirubin 128
PCO2 (on blood gas) 128
Admission haemoglobin 113
Anaemia 127
Fibrinolysis 139
Glycaemic Status (not including Hba1c above)
Glycaemic variability 134
Mean capillary blood
glucose
138
Insulin resistance 138
5T. Mukherjee et al. / Journal of Diabetes and Its Complications xxx (xxxx) xxxAll the papers used statistical tests to assess the impact of potential
risk factors and evaluate their significance. Statistical significance was
set at a standard of p-value less than 0.05. The majority of the papers,
which was 14 in number (40%), used Cox proportional hazards model.Please cite this article as: T.Mukherjee, T. Robbins, S.N. LimChoi Keung, et a
discharged from hospital with..., Journal of Diabetes and Its Complications7 papers (20%) had not defined their statistical test, 5 papers (14%)
used univariate and multivariate Cox regression analysis, 3 studies
(8%) utilised univariate and multivariate analysis, 2 papers (6%) used
multivariate analysis, 1 study (3%) used multivariate binary logistic re-
gression, 1 study used Kaplan Meir curves (3%), 1 study used sensitivity
analysis (3%) and finally 1 additional study (3%) used parametric and
non-parametric tests. No studies considered the application of stan-
dardized effect size measures; there was very limited calculation of
power sizes, in advance, to identify and appropriate population size
for the study.
4. Discussion
The identification of risk factors, following discharge from hospital is
an important consideration for patients, clinicians, managers and policy
makers. This review represents the first systematic collection and iden-
tification of risk factors for mortality in the published research litera-
ture. We identify a total of 48 distinct, statistically significant risk
factors across 9 categories reported in 35 studies. The most commonly
reported risk factor was age, followed by co-morbidity burden.
Thirty-seven of the risk factors were only identified as statistically sig-
nificant in a single research paper. We would argue that this represents
a research literature that is at a relatively early stage of maturity, in con-
sidering this important topic area.
The quality of studies identified was relatively high, with accept-
able sample sizes, albeit frequently lacking a power-calculation for
the results reported. The statistical tests used were acceptable,
with the majority using Cox proportional hazard models. The small
number of papers not defining the statistical test used was however
concerning. A large proportion of the extracted articles represented
conference abstracts rather than full research papers. These confer-
ence abstracts are typically shorter, lack full methodological detail
and often do not undergo such rigorous peer review. This again sup-
ports the argument that the research literature in this area is at an
early stage of maturity.
The results presented in this paper can be compared to a similar
review that considered risk factors, specifically for readmission,
when patients with diabetes are discharged from hospital.7 In the re-
view, considering readmission, a significantly larger number of stud-
ies were reported (82 studies compared to 35) and 72 distinct risk
factors were identified, in comparison to the 48 statistically signifi-
cant risk factors identified here. There is a higher proportion of con-
ference abstracts within the mortality articles, as compared to the
readmission articles, and the mortality articles included fewer re-
ports of prospective studies, compared to the readmission papers.
These comparisons, therefore, contrast the early state of the research
literature for mortality risk factors with a more complete picture
seen relating to risk factors, for readmission. Readmission and post-
discharge mortality are both important negative outcomes, in the
context of discharge from hospitals. Clinicians, managers and policy
makers are motivated to reduce both outcomes. However, it is
more typically avoiding readmission that is associated with financial
incentivisation for clinical providers. This incentivisation, alongside
readmission typically happening sooner than mortality events, may
have led researchers more towards conducting readmission rather
than mortality studies. However, mortality is undoubtedly a vitally
important consideration for all those involved with the discharge
process and it is important that adequate research resource is di-
rected towards this outcome.
The strengths of this research include the PRISMA approach to
reporting, the use of Keshav's 5Cs approach to quality assessment and
the level of detail in data collection. There are however a number of lim-
itations that should be considered. The research only considers papers
published in the English Language; theremay be other risk factors iden-
tified in other studies that are published in different languages. Further-
more, the study only considers papers published over the last 6 years.l., A systematic review considering risk factors formortality of patients
, https://doi.org/10.1016/j.jdiacomp.2020.107705
6 T. Mukherjee et al. / Journal of Diabetes and Its Complications xxx (xxxx) xxxThis ensures that all risk factors identified are relevant to current med-
ical practice, although it is possible that previously identified risk factors
may be also identified. Finally, the search term used to identify dis-
charge fromhospitalwas only “discharge,” this is a relatively universally
accepted term for when a patient leaves hospital following an inpatient
admission, however it is possible that a very small number of articles
used an alternative descriptor and therefore the results should be
interpreted with awareness of this.
There is a lot of scope and future work that can be recommended,
based on this systematic review. The identified significant risk factors
can be stratified according to their effectiveness in predicting mortality
in type 2 diabetes patients, following their discharge from hospitals.
These will highlight patients who are most vulnerable and need special
attention. Additionally, available EHR based predictive tools, such as
“deep learning” models that use machine learning techniques and
could potentially be used for risk prediction of mortality in such pa-
tients, could be found out. Following this step, the feasibility of the cho-
sen predictive tools can be examined and validated. Such evaluated
tools for risk prediction can be integratedwithin the EHR system, to pre-
dict the risk ofmortality post hospital discharge tailored for each patient
who has type 2 diabetes.
5. Conclusions
Mortality, following hospital discharge, is necessarily an important
outcome of relevance to patients, carers, clinicians and policymakers.
This review is the first systematic collection of risk factors identified
for mortality for patients being discharged from hospital with diabetes.
The review demonstrates that the literature is at an early stage of matu-
rity, particularly in comparison to the literature considering risks factors
for readmission following discharge. This research is particularly impor-
tant for the future development of risk prediction models that can sup-
port the better identification of patients atmost risk, and the tailoring of
support strategies to individual patient needs in an evidence-based
manner.
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